Skip to main content

Samantha

Analyst

Cantor

Equibles does not estimate personal net worth.

About Samantha

Samantha is recorded as Analyst at Cantor. Samantha has spoken on 2 earnings calls across 1 company, most recently for Acumen Pharmaceuticals, Inc. on August 12, 2026. The companies whose calls Samantha spoke on are classified in the Healthcare sector.

Samantha on recent calls

“My first question is, there are biomarker data that suggests certain tau fragments like P-tau-217 can be used as a marker for amyloid pathology, while markers like MTBR tau-243 identifies tau-tangle pathology in Alzheimer's disease.”
Analyst — Cantor, Acumen Pharma Q2 2026 Conference Call and Webcast ·
“So, my first question, I know we're about a year or so away from altitude data, but I'm wondering what your current thinking is in terms of the bar and what's the minimum you'd like to see out of this study to move forward from both a clinical scale perspective and biomarker data?”
Analyst — Cantor, Acumen Pharmaceuticals, Inc. Q3 FY2025 Earnings Call ·

Affiliation history

  • Cantor

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity